Get the app
US › Healthcare

CalciMedica, Inc. Common Stock (CALC)

US · Healthcare · Biotechnology

$1.04-3.70%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-7.7M
EPS
$-0.45
EPS estimate
$-0.33

EPS came in at -0.45 against a street estimate of -0.33 — a miss of 36.4%.

Key statistics

Market cap
$8.7M
Forward P/E
0.0
P/B
2.22
Book value
$0.90
EPS (TTM)
$-6.85
52-week high
$36.00
52-week low
$1.27
50-day MA
$2.43
200-day MA
$6.15
Beta
1.10

Analyst view

Analysts rate CalciMedica, Inc. Common Stock a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $50.00.

Shareholding

Insiders
18.53%
Institutions
57.51%

Largest institutional holders

FundStake
Woodline Partners LP7.29%
Heights Capital Management Inc4.56%
StemPoint Capital LP3.65%
Squadron Capital Management LLC3.65%
Stonepine Capital Management Llc1.82%
L1 Global Manager Pty Ltd0.73%
Morgan Stanley - Brokerage Accounts0.42%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.35%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CalciMedica, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.